ページ6 - 最高の幹細胞若返り療法医師 - トップ102名の医師

Key International Publication
Kim JW, Li MH, Jang JH, Na HK, Song NY, Lee C, Johnson JA, Surh YJ.
“15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ rescues PC12 cells from H₂O₂-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.”
Biochemical Pharmacology. 2008 Dec 1;76(11):1577–1589.

International Conference Presentations

The International Meeting of the Society for Free Radical Research–Asia, Nov 6–8, 2003, Seoul, Korea

The 3rd International Congress of the Asian Society of Toxicology, Feb 1–6, 2003, Bangkok & Chiang Mai, Thailand

Domestic Conference Presentations

The Pharmaceutical Society of Korea Annual Meeting, Oct 10–11, 2003, Seoul, Korea

The 19th Annual Meeting of the Korean Societies of Toxicology, May 30, 2003, Seoul, Korea

The 20th Annual Meeting of the Korean Societies of Toxicology, Oct 30, 2003, Seoul, Korea

The 58th Annual Fall Meeting of the Korean Pediatric Society, Oct 23–24, 2009, Sheraton Walkerhill, Seoul, Korea

The Annual Fall Meeting of the Korean Academy of Family Medicine, Oct 10–12, 2014, Seoul, Korea

Assoc. Prof. Dr. Metin Aytekin is a Clinical Biochemist and Molecular Medicine specialist. He holds an adjunct position at the Cleveland Clinic, USA. He also serves as Associate Professor at Erciyes University, Turkey. Dr. Aytekin is Vice President of the Genome and Stem Cell Center (GENKÖK). He played a key role in establishing one of Turkey’s largest stem cell centers.

Dr. Aytekin has published over 40 peer-reviewed articles. His research focuses on pulmonary hypertension, lung diseases, coronary atherosclerosis, and cardiotoxicity. He has received several awards, including the American Heart Association Postdoctoral Training Award and institutional honors for research and publication quality. His work has contributed to advances in biomarker discovery and molecular diagnostics for cardiovascular and pulmonary diseases.